Selective internalization of monoclonal antibodies by B-cell chronic lymphocytic leukaemia cells.
about
Ofatumumab, a human anti-CD20 monoclonal antibody.Targeted Cancer Therapy with a Novel Anti-CD37 Beta-Particle Emitting Radioimmunoconjugate for Treatment of Non-Hodgkin Lymphoma.Estimation of dose requirements for sustained in vivo activity of a therapeutic human anti-CD20 antibody.Macrophage and NK-mediated killing of precursor-B acute lymphoblastic leukemia cells targeted with a-fucosylated anti-CD19 humanized antibodiesRituximab for the treatment of diffuse large B-cell lymphomas.Rituximab and its role as maintenance therapy in non-Hodgkin lymphoma.The antileukemia activity of a human anti-CD40 antagonist antibody, HCD122, on human chronic lymphocytic leukemia cellsAnti-CD45 radioimmunotherapy using (211)At with bone marrow transplantation prolongs survival in a disseminated murine leukemia model.Differential cellular internalization of anti-CD19 and -CD22 immunotoxins results in different cytotoxic activity.Unresolved issues in diffuse large B-cell lymphomas.The future of CD20 monoclonal antibody therapy in B-cell malignancies.Radiolabeled antibodies directed at CD45 for conditioning prior to allogeneic transplantation in acute myeloid leukemia and myelodysplastic syndrome.Two Saporin-Containing Immunotoxins Specific for CD20 and CD22 Show Different Behavior in Killing Lymphoma Cells.CD22 is a recycling receptor that can shuttle cargo between the cell surface and endosomal compartments of B cells.Internalisation of uncross-linked rituximab is not essential for the induction of caspase-independent killing in Burkitt lymphoma cell lines.High CD21 expression inhibits internalization of anti-CD19 antibodies and cytotoxicity of an anti-CD19-drug conjugate.
P2860
Q34095311-63340155-C977-444D-90F8-E388057F5A59Q34480345-8FB4CB47-F920-49DB-A9E2-C24284A34803Q34585485-82D30C44-912A-4369-94EA-829FF9393A7CQ34598149-1928888D-2199-4FD2-8B99-A5665457DB74Q36573823-9BED5B82-D2C9-4F0E-9852-BDD4183E5F85Q36752014-AED77447-BB53-4796-A1D7-54818E85EB27Q36787532-E1221123-730E-4BC6-9A72-F1A17368C212Q36814661-45A3BAD0-1992-4CCE-BEF7-56D47518D790Q36923799-D92965DF-006A-48F0-A129-F60EE1587044Q37705417-D0A5E2AB-D5D8-47FE-8265-F0BF1DA72830Q37724396-94A3E046-6D2F-420C-87A7-B3C023741B39Q38095962-7F79A7CA-CF29-41DF-B1E3-FCC65DE722B4Q38701886-72797FD8-4566-4099-9A4E-21950F412B90Q39617063-7DF6092E-FA32-469B-8B1D-523B2CECC022Q39944187-8483AEA1-47D9-4926-AFCF-CBEB00608479Q40054666-2FCFA69C-3729-4C48-B65D-744A8C8A2973
P2860
Selective internalization of monoclonal antibodies by B-cell chronic lymphocytic leukaemia cells.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Selective internalization of m ...... c lymphocytic leukaemia cells.
@ast
Selective internalization of m ...... c lymphocytic leukaemia cells.
@en
type
label
Selective internalization of m ...... c lymphocytic leukaemia cells.
@ast
Selective internalization of m ...... c lymphocytic leukaemia cells.
@en
prefLabel
Selective internalization of m ...... c lymphocytic leukaemia cells.
@ast
Selective internalization of m ...... c lymphocytic leukaemia cells.
@en
P2093
P2860
P921
P1476
Selective internalization of m ...... c lymphocytic leukaemia cells.
@en
P2093
Dagmar Schoeler
Folke Schriever
Frauke Ringel
Maria Pascu
Thomas Sieber
P2860
P304
P356
10.1046/J.1365-2141.2003.04305.X
P407
P577
2003-05-01T00:00:00Z